Quantification of ribonucleotide reductase expression in wild-type and hydroxyurea-resistant cell lines employing in situ reverse transcriptase polymerase chain reaction and a computerized image analysis system

Analytical Biochemistry

Volumn 267, Issue 1, 1999, Pages 24-29

  Wadler, Scott ^a   Zhang, Hongyang ^a   Cammer, Michael ^a   Hu, Xiou Ping ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Drug resistance; Gene expression; Hydroxyurea; In situ RT PCR; Ribonucleotide reductase

Indexed keywords

CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; FREE RADICALS; GENE EXPRESSION; GROWTH KINETICS; IMAGE ANALYSIS; TRANSCRIPTION;

DRUG RESISTANCE; HYDROXYUREA; IMAGE ANALYSIS SYSTEMS; NUCLEOSIDE DIPHOSPHATES; REVERSE TRANSCRIPTASE- POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASES; RIBONUCLEOTIDE REDUCTASE; SITU RT-PCR;

POLYMERASE CHAIN REACTION;

FREE RADICAL; HYDROXYUREA; NUCLEOSIDE DERIVATIVE; RIBONUCLEOTIDE REDUCTASE;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL SIZE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMAGE ANALYSIS; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033080769     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1998.2890     Document Type: Article

References (21)

1. Femino A. M., Fay F. S., Fogarty K., Singer R. H. Visualization of single RNA transcripts in situ. Science. 280:1998;585-590.
2. Bagasra O., Pomerantz R. J. Human immunodeficiency virus type I provirus is demonstrated in peripheral blood monocytes in vivo: A study utilizing an in situ polymerase chain reaction. AIDS Res. Hum. Retroviruses. 9:1993;69-76.
3. Mehta A., Maggioncalda J., Bagasra O., Thikkavarapu S., Saikumari P., Valyi-Nagy T., Fraser N. W., Block T. R. In situ DNA PCR and DNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology. 206:1995;633-640.
4. Bagasra O., Hauptman S. P., Lisohner H. W., Sachs M., Pomerantz R. J. Detection of human immunodeficiency virus type I provirus in mononuclear cells by in situ polymerase chain reaction. N. Engl. J. Med. 326:1992;1385-1391.
5. Pereira R. F., Halford K. W., O'Hara M. D., Leeper D. B., Sokolov B. P., Pollard M. D., Bagasra O., Prockop B. J. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in irradiated mice. Proc. Natl. Acad. Sci. USA. 92:1995;4857-4861.
6. Nuovo G. J., MacConnell P., Forde A. Detection of human papillomavirus DNA in formalin fixed tissues by in situ hybridization after PCR. Am. J. Pathol. 139:1991;847-854.
7. Zhang H., Wadler S. Micropreparation of cultured cells forin situ. Biotechniques. 22:1997;619-624.
8. Stubbe J. Ribonucleotide reductases: Amazing and confusing. J. Biol. Chem. 265:1990;5329-5332.
9. Thelander L., Berg P. Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase. Mol. Cell. Biol. 6:1986;3433-3442.
10. Eriksson S., Graslund A., Skog S., Thelander L., Tribukait B. Cell-cycle dependent regulation of mammalian ribonucleotide reductase. J. Biol. Chem. 259:1984;11695-11700.
11. Engstrom Y., Rozell B., Hansson H.-A., Stemme S., Thelander L. Localization of ribonucleotide reductase in mammalian cells. EMBO J. 3:1988;863-867.
12. Mann G. J., Musgrove E. A., Fox R. M., Thelander L. Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence and differentiation. Cancer Res. 48:1988;5151-5156.
13. Bjorklund S., Skog S., Tribukait B., Thelander L. S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry. 29:1990;5452-5458.
14. McClarty G. M., Chan A. K., Choy B. K., Thelander L., Wright J. A. Molecular mechanisms responsible for the drug-induced post-transcriptional modulation of ribonucleotide reductase levels in a hydroxyurea-resistant mouse L cell line. Biochemistry. 27:1988;7524-7531.
15. Pavloff N., Rivard D., Masson S., Shen S.-H., Mes-Masson A.-M. Sequence analysis of the large and small subunits of human ribonucleotide reductase: DNA Sequence. J. DNA Sequencing Mapping. 2:1992;227-234.
16. Wadler S., Horowitz R., Rao J., Mao X., Schlesinger K., Schwartz E. L. Interferon augments the cytotoxicity of hydroxyurea without enhancing its activity against the M2 subunit of ribonucleotide reductase: effects in wild-type and resistant human colon cancer cells. Cancer. Chemother. Pharmacol. 38:1996;522-528.
17. SAS Procedures Guide, Version 6, Third edition. 1990;SAS Institute, Inc. Cary.
18. Choy B. K., McClarty G. A., Chan A. K., Thelander L., Wright J. A. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations. Cancer Res. 48:1988;2029-2035.
19. Zhou B.-S., Hsu N.-Y., Pan B.-C., Doroshow J. H., Yen Y. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2, but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells. Cancer Res. 55:1995;1328-1333.
20. Wadler S., Horowitz R., Zhang H. Y., Schwartz E. L. Depletion of deoxyribonucleotide triphospates fails to inhibit expression of the G1/S transition state enzyme, ribonucleotide reductase. Biochem. Pharmacol. 55:1998;1353-1360.
21. Huang A., Fan H., Taylor W. R., Wright J. A. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability. Cancer Res. 57:1997;4876-4881.